These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 3954813)

  • 1. A new procedure to immobilize polyriboinosinic-polyribocytidylic acid (poly I:C) on the surface of polymethylmethacrylate and the use of poly I:C in clinical hemoperfusion.
    Hydén H; Holmberg K
    Arzneimittelforschung; 1986; 36(1):120-3. PubMed ID: 3954813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods of immobilization of proteins to polymethylmethacrylate.
    Holmberg K; Hydén H
    Prep Biochem; 1985; 15(5):309-19. PubMed ID: 3938844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Eastern Cooperative Oncology Group phase I-II pilot study of polyriboinosinic-polyribocytidylic acid poly-L-lysine complex in patients with metastatic malignant melanoma.
    Hawkins MJ; Levin M; Borden EC
    J Biol Response Mod; 1985 Dec; 4(6):664-8. PubMed ID: 2418164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal interferon therapy in malignant melanoma. Significant economies of interferon in an extracorporeal chamber.
    Langvad E; Hydén H; Petersen JK; Jordal R; Olsen G
    Arzneimittelforschung; 1980; 30(8):1245-6. PubMed ID: 6159905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditioned augmentation of natural killer cell activity. Independence from nociceptive effects and dependence on interferon-beta.
    Solvason HB; Ghanta VK; Hiramoto RN
    J Immunol; 1988 Jan; 140(2):661-5. PubMed ID: 2826599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of human and mouse interferon and of polyriboinosinic acid.polyribocytidylic acid on the growth of human fibrosarcoma and melanoma tumors in nude mice.
    de Clercq E; Georgiades J; Edy VG; Sobis H
    Eur J Cancer (1965); 1978 Nov; 14(11):1273-82. PubMed ID: 738332
    [No Abstract]   [Full Text] [Related]  

  • 7. Ssytemic effects of intravenous polyriboinosinic-polyribocytidylic acid in man.
    Cornell CJ; Smith KA; Cornwell GG; Burke GP; McIntyre OR
    J Natl Cancer Inst; 1976 Dec; 57(6):1211-6. PubMed ID: 1069859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.
    Hafner AM; Corthésy B; Merkle HP
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of bone marrow transplantation and polyinosinic-polycytidylic acid (poly I:C) on the rescue of animals from busulfan-induced NK suppression.
    Bhoopalam N; Fried W; Benson D; Barone-Verales J; Price K
    Exp Hematol; 1989 May; 17(4):357-63. PubMed ID: 2651135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
    Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors.
    Robinson RA; DeVita VT; Levy HB; Baron S; Hubbard SP; Levine AS
    J Natl Cancer Inst; 1976 Sep; 57(3):599-602. PubMed ID: 978771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-step immobilization of aminated and thiolated DNA onto poly(methylmethacrylate) (PMMA) substrates.
    Fixe F; Dufva M; Telleman P; Christensen CB
    Lab Chip; 2004 Jun; 4(3):191-5. PubMed ID: 15159777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer.
    Levine AS; Sivulich M; Wiernik PH; Levy HB
    Cancer Res; 1979 May; 39(5):1645-50. PubMed ID: 371793
    [No Abstract]   [Full Text] [Related]  

  • 14. Augmented antitumor effect of combined human natural interferon-alpha and mismatched double-stranded RNA treatment against a human malignant melanoma xenograft.
    Hubbell HR; Pequignot EC; Todd J; Raymond LC; Mayberry SD; Carter WA; Strayer DR
    J Biol Response Mod; 1987 Oct; 6(5):525-36. PubMed ID: 3681346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of mouse interferon and polyriboinosinic acid-polyribocytidylic acid on L-cell tumor growth in nude mice.
    Clercq ED
    Cancer Res; 1977 May; 37(5):1502-6. PubMed ID: 856466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of human natural killing. III. Mechanism for interferon induction of loss of susceptibility to suppression by cyclic AMP elevating agents.
    Leung KH; Koren HS
    J Immunol; 1984 Mar; 132(3):1445-50. PubMed ID: 6319493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of human recombinant interleukin-2 on cytotoxic response of peripheral blood mononuclear cells in melanoma patients before surgery.
    Jira M; Strejcek J; Chodounsky Z; Fuchsova M; Tomasova M; Faltyn J; Suchomelova M
    Arch Geschwulstforsch; 1987; 57(5):379-84. PubMed ID: 3500690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducing a mode of NK-resistance to suppression by stress and surgery: a potential approach based on low dose of poly I-C to reduce postoperative cancer metastasis.
    Rosenne E; Shakhar G; Melamed R; Schwartz Y; Erdreich-Epstein A; Ben-Eliyahu S
    Brain Behav Immun; 2007 May; 21(4):395-408. PubMed ID: 17240115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma.
    Jiang Q; Wei H; Tian Z
    J Immunother; 2008; 31(6):555-62. PubMed ID: 18528299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
    Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
    Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.